Viral Vaccines
Suspensions of attenuated or killed viruses administered for the prevention or treatment of infectious viral disease. A DrugBank category of 122 drugs. 106 of them are approved.
- ATC classification
- Part of
- Vaccines
- Also known as
- Vaccines, Viral
- Drugs
- Abdavomeran
- Adenovirus type 7 vaccine live
- Andusomeran
- AstraZeneca COVID-19 Vaccine
- BBIBP-CorV
- BBV152
- Bizalimogene ralaplasmid
- BNT-162A1
- BNT162B2 Omicron (LP.8.1)
- Chikungunya vaccine (live, attenuated)
- CoronaVac
- CoVac-1
- Davesomeran
- Dengue tetravalent vaccine, live
- Ebola Zaire vaccine (live, attenuated)
- Elasomeran
- EpiVacCorona
- Famtozinameran
- Hepatitis A Vaccine
- Hepatitis B Vaccine (Recombinant)
- Human adenovirus e serotype 4 strain cl-68578 antigen
- Imelasomeran
- Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated)
- Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated)
- Influenza A Virus A/California/122/2022 SAN-022 (H3N2) antigen (formaldehyde inactivated)
What you can answer from here — as of August 12, 2022
Which targets do Viral Vaccines share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account